TY - JOUR
T1 - Evaluation of the effect of remission plasma on untreated patients with burkitt’s lymphoma
AU - Fass, Leroy
AU - Herberman, Ronald B.
AU - Ziegler, John
AU - Morrow, Richard H.
N1 - Funding Information:
1 Received July 28, 1969; accepted September 26, 1969. 2 Supported by Public Health Service contracts PH-43-67-1343 and PH-43-67-47 from the National Cancer Institute. 3 Medicine Branch, National Cancer Institute. 4 Immunology Branch, National Cancer Institute. 5 Department of Preventive Medicine, Makerere University College Medical School, Kampala, Uganda. 6 National Institutes of Health, Public Health Service, U.S. Department of Health, Education, and Welfare~
PY - 1970/1
Y1 - 1970/1
N2 - In a controlled study, eight patients with untreated Burkitt's lymphoma were given plasma from patients with Burkitt’s lymphoma in remission or from normal volunteers. Although the donor plasma was shown to have in vitro antibody activity, no evidence for in vivo antitumor activity was noted. This preliminary study does not confirm previous reports of in vivo antitumor activity in the plasma of patients with Burkitt’s lymphoma.—J Nat Cancer Inst 44: 145-149,1970.
AB - In a controlled study, eight patients with untreated Burkitt's lymphoma were given plasma from patients with Burkitt’s lymphoma in remission or from normal volunteers. Although the donor plasma was shown to have in vitro antibody activity, no evidence for in vivo antitumor activity was noted. This preliminary study does not confirm previous reports of in vivo antitumor activity in the plasma of patients with Burkitt’s lymphoma.—J Nat Cancer Inst 44: 145-149,1970.
UR - http://www.scopus.com/inward/record.url?scp=0014730762&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0014730762&partnerID=8YFLogxK
U2 - 10.1093/jnci/44.1.145
DO - 10.1093/jnci/44.1.145
M3 - Article
C2 - 11515025
AN - SCOPUS:0014730762
SN - 0027-8874
VL - 44
SP - 145
EP - 149
JO - Journal of the National Cancer Institute
JF - Journal of the National Cancer Institute
IS - 1
ER -